IMPEL NEUROPHARMA INC·4

Oct 21, 5:31 PM ET

Leaman John Harold 4

4 · IMPEL NEUROPHARMA INC · Filed Oct 21, 2021

Insider Transaction Report

Form 4
Period: 2021-10-19
Leaman John Harold
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units (RSUs)

    2021-10-19+10,57110,571 total
    Exp: 2031-10-19Common Stock (10,571 underlying)
Footnotes (2)
  • [F1]Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
  • [F2]The RSUs vest as to 100% of the total shares on December 31, 2022, subject to the reporting person's continuation of employment on such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION